Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins
Open Access
- 12 March 2007
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (38) , 5553-5563
- https://doi.org/10.1038/sj.onc.1210351
Abstract
Cancer cells display an altered distribution of DNA methylation relative to normal cells. Certain tumor suppressor gene promoters are hypermethylated and transcriptionally inactivated, whereas repetitive DNA is hypomethylated and transcriptionally active. Little is understood about how the abnormal DNA methylation patterns of cancer cells are established and maintained. Here, we identify over 20 DNMT3B transcripts from many cancer cell lines and primary acute leukemia cells that contain aberrant splicing at the 5′ end of the gene, encoding truncated proteins lacking the C-terminal catalytic domain. Many of these aberrant transcripts retain intron sequences. Although the aberrant transcripts represent a minority of the DNMT3B transcripts present, Western blot analysis demonstrates truncated DNMT3B isoforms in the nuclear protein extracts of cancer cells. To test if expression of a truncated DNMT3B protein could alter the DNA methylation patterns within cells, we expressed DNMT3B7, the most frequently expressed aberrant transcript, in 293 cells. DNMT3B7-expressing 293 cells have altered gene expression as identified by microarray analysis. Some of these changes in gene expression correlate with altered DNA methylation of corresponding CpG islands. These results suggest that truncated DNMT3B proteins could play a role in the abnormal distribution of DNA methylation found in cancer cells.Keywords
This publication has 53 references indexed in Scilit:
- Splicing Factor Tra2-β1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of theCD44GeneCancer Research, 2006
- Suppression of Intestinal Neoplasia by Deletion of Dnmt3bMolecular and Cellular Biology, 2006
- Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumorsOncogene, 2006
- DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation systemBiochemical and Biophysical Research Communications, 2004
- RasGRP4 Is a Novel Ras Activator Isolated from Acute Myeloid LeukemiaJournal of Biological Chemistry, 2002
- Three novel DNMT3B mutations in Japanese patients with ICF syndromeAmerican Journal of Medical Genetics, 2002
- RasGRP4, a New Mast Cell-restricted Ras Guanine Nucleotide-releasing Protein with Calcium- and Diacylglycerol-binding MotifsJournal of Biological Chemistry, 2002
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Dnmt3b, de Novo DNA Methyltransferase, Interacts with SUMO-1 and Ubc9 through Its N-Terminal Region and Is Subject to Modification by SUMO-1Biochemical and Biophysical Research Communications, 2001
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityPublished by Elsevier ,1992